עקוב אחר
Lucija Kuna
Lucija Kuna
Department of pharmacology and biochemistry, Faculty of dental medicine and health Osijek
כתובת אימייל מאומתת בדומיין fdmz.hr
כותרת
צוטט על ידי
צוטט על ידי
שנה
Peptic ulcer disease: a brief review of conventional therapy and herbal treatment options
L Kuna, J Jakab, R Smolic, N Raguz-Lucic, A Vcev, M Smolic
Journal of clinical medicine 8 (2), 179, 2019
4082019
Models of drug induced liver injury (DILI)–current issues and future perspectives
L Kuna, I Bozic, T Kizivat, K Bojanic, M Mrso, E Kralj, R Smolic, GY Wu, ...
Current drug metabolism 19 (10), 830-838, 2018
1442018
HCV extrahepatic manifestations
L Kuna, J Jakab, R Smolic, GY Wu, M Smolic
Journal of Clinical and Translational Hepatology 7 (2), 172, 2019
1222019
Targeting the Wnt signaling pathway in liver fibrosis for drug options: an update
K Duspara, K Bojanic, JI Pejic, L Kuna, TO Kolaric, V Nincevic, R Smolic, ...
Journal of clinical and translational hepatology 9 (6), 960, 2021
472021
Antioxidant pre-treatment reduces the toxic effects of oxalate on renal epithelial cells in a cell culture model of urolithiasis
T Kizivat, M Smolić, I Marić, M Tolušić Levak, R Smolić, I Bilić Čurčić, ...
International journal of environmental research and public health 14 (1), 109, 2017
432017
Drug-induced fatty liver disease: Pathogenesis and treatment
TO Kolaric, V Nincevic, L Kuna, K Duspara, K Bojanic, S Vukadin, ...
Journal of clinical and translational hepatology 9 (5), 731, 2021
382021
Impact of DAA treatment on cardiovascular disease risk in chronic HCV infection: an update
H Roguljic, V Nincevic, K Bojanic, L Kuna, R Smolic, A Vcev, D Primorac, ...
Frontiers in pharmacology 12, 678546, 2021
322021
Obesity paradox in chronic liver diseases: product of bias or a real thing?
IB Curcic, MC Berkovic, L Kuna, H Roguljic, R Smolic, SC Varzic, LV Jukic, ...
Journal of clinical and translational hepatology 7 (3), 275, 2019
272019
The role of GLP1-RAs in direct modulation of lipid metabolism in hepatic tissue as determined using in vitro models of NAFLD
A Petrovic, D Igrec, K Rozac, K Bojanic, L Kuna, TO Kolaric, V Mihaljevic, ...
Current issues in molecular biology 45 (6), 4544-4556, 2023
242023
Glycosylation alterations in cancer cells, prognostic value of glycan biomarkers and their potential as novel therapeutic targets in breast cancer
L Peric, S Vukadin, A Petrovic, L Kuna, N Puseljic, R Sikora, K Rozac, ...
Biomedicines 10 (12), 3265, 2022
152022
Antimicrobial resistance and antimicrobial stewardship: Before, during and after the COVID-19 pandemic
O Khaznadar, F Khaznadar, A Petrovic, L Kuna, A Loncar, ...
Microbiology Research 14 (2), 727-740, 2023
122023
Mechanistic-based classification of endocytosis-related inhibitors: does it aid in assigning drugs against SARS-CoV-2?
M Hessien, T Donia, AA Tabll, E Adly, TH Abdelhafez, A Attia, SS Alkafaas, ...
Viruses 15 (5), 1040, 2023
122023
Molecular mechanisms linking empagliflozin to renal protection in the LLC-PK1 model of diabetic nephropathy
V Mihaljević, M Zjalić, T Kizivat, T Omanović Kolarić, M Smolić, E Rođak, ...
Biomedicines 10 (11), 2983, 2022
92022
Pretreatment of garlic oil extracts hampers epithelial damage in cell culture model of peptic ulcer disease
L Kuna, M Zjalic, T Kizivat, H Roguljic, V Nincevic, T Omanovic Kolaric, ...
Medicina 58 (1), 91, 2022
92022
Representation of CYP3A4, CYP3A5 and UGT1A4 polymorphisms within Croatian breast cancer patients’ population
K Bojanic, L Kuna, I Bilic Curcic, J Wagner, R Smolic, K Kralik, T Kizivat, ...
International journal of environmental research and public health 17 (10), 3692, 2020
92020
Liraglutide Exerts Protective Effects by Downregulation of PPARγ, ACSL1 and SREBP-1c in Huh7 Cell Culture Models of Non-Alcoholic Steatosis and Drug …
T Omanovic Kolaric, T Kizivat, V Mihaljevic, M Zjalic, I Bilic-Curcic, L Kuna, ...
Current issues in molecular biology 44 (8), 3465-3480, 2022
82022
The role of direct oral anticoagulants in the era of COVID-19: are antiviral therapy and pharmacogenetics limiting factors?
H Roguljić, J Arambašić, V Ninčević, L Kuna, I Šesto, A Tabll, R Smolić, ...
Croatian medical journal 63 (3), 287, 2022
82022
Renoprotective effect of liraglutide is mediated via the inhibition of TGF-beta 1 in an LLC-PK1 cell model of diabetic nephropathy
V Ninčević, M Zjalić, TO Kolarić, M Smolić, T Kizivat, L Kuna, A Včev, ...
Current issues in molecular biology 44 (3), 1087-1114, 2022
72022
Association of Wnt Inhibitors, Bone Mineral Density and Lifestyle Parameters in Women with Breast Cancer Treated with Anastrozole Therapy
K Bojanić, I Bilić Ćurčić, L Kuna, T Kizivat, R Smolic, N Raguž Lučić, ...
Journal of clinical medicine 7 (9), 287, 2018
42018
Preclinical models and promising pharmacotherapeutic strategies in liver fibrosis: an update
TO Kolaric, L Kuna, M Covic, H Roguljic, A Matic, R Sikora, M Hefer, ...
Current issues in molecular biology 45 (5), 4246-4260, 2023
32023
המערכת אינה יכולה לבצע את הפעולה כעת. נסה שוב מאוחר יותר.
מאמרים 1–20